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Background and PurposeᄏBenign paroxysmal positional vertigo (BPPV) is the most com-
mon form of vertigo. Although the repositioning maneuver dramatically improves the vertigo, 
some patients complain of residual dizziness. We evaluated the incidence and characteristics of 
persistent dizziness after successful particle repositioning and the clinical factors associated with 
the residual dizziness. 
MethodsᄏWe performed a prospective investigation in 49 consecutive patients with confirmed 
BPPV. The patients were treated with a repositioning maneuver appropriate for the type of 
BPPV. Success was defined by the resolution of nystagmus and positional vertigo. All patients 
were followed up until complete resolution of all dizziness, for a maximum of 3 months. We col-
lected data on the characteristics and duration of any residual dizziness and analyzed the cli-
nical factors associated with the residual dizziness.   
ResultsᄏOf the 49 patients, 11 were men and 38 were women aged 60.4±13.0 years (mean
±SD), and 30 (61%) of them complained of residual dizziness after successful repositioning 
treatment. There were two types of residual dizziness: continuous lightheadedness and short-
lasting unsteadiness occurring during head movement, standing, or walking. The dizziness lasted 
for 16.4±17.6 days (range=2-80 days, median=10 days). A longer duration of BPPV before 
treatment was significantly associated with residual dizziness (p=0.04). 
ConclusionsᄏResidual dizziness after successful repositioning was observed in two-thirds of 
the patients with BPPV and disappeared within 3 months without specific treatment in all cases. 
The results indicate that early successful repositioning can reduce the incidence of residual 
dizziness.  J Clin Neurol 2008;4:107-110
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Introduction 
 
Benign paroxysmal positional vertigo (BPPV) is the most 
common cause of vertigo.
1,2 The diagnosis is confirmed by 
provocation maneuvers, such as the Dix-Hallpike test
3,4 or 
the supine head-turning test,
5 and repositioning maneuvers 
represent an effective therapy. Although the repositioning 
maneuvers usually dramatically improve the vertigo, some 
patients report residual dizziness. This study evaluated the 
incidence and characteristics of residual dizziness after suc-
cessful particle repositioning and to determine the predictors 
of this condition. 
 
Methods 
 
A prospective study was performed in 49 consecutive pa-
tients with confirmed BPPV from March to October 2007. 
The diagnosis was based on a history of recurrent positional 
vertigo and the results of the Dix-Hallpike and supine head-
turning tests. The Dix-Hallpike test was considered positive 
if nystagmus was recorded with appropriate positioning, la-
tency, duration, and fatigue, and reversed when the patient 
resumed a sitting position. With the affected ear down, geo-
tropic torsional nystagmus (i.e., the upper poles of the eyes 
beating to the lowermost ear) occurs with an up-beating com-
ponent for the posterior canal (PC) and a down-beating com-
ponent for the anterior canal (AC). Horizontal canal (HC) 
BPPV was diagnosed by horizontal direction-changing posi-
tional nystagmus concurrent with vertigo elicited by the su-
pine head-turning test. Patients were divided into canaloli-
thiasis and cupulolithiasis groups according to the direction 
of the nystagmus.  
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We collected information on demographic characteristics, 
the clinical features of the BPPV, the history of BPPV, and 
concurrent diseases, including hypertension, diabetes mellitus, 
heart disease, and hyperlipidemia. The clinical features of 
BPPV include the affected side, involved canal, duration of 
vertigo, total number of vertigo attacks before treatment, and 
cause of BPPV. The duration of vertigo was defined as the 
duration from the first episode to successful treatment (i.e., 
not the duration of a single vertigo episode). We identified 
the etiology of BPPV as idiopathic, vestibular neuronitis (pa-
tients with a history of acute vestibulopathy on the affected 
side), or traumatic. The etiology was considered traumatic if 
the symptoms appeared within 1 week after head trauma. 
The information was collected in a structured interview with 
the patients and using videooculography. 
The patients were treated with the repositioning maneuver 
appropriate for the type of BPPV.
6-9 Patients with PC BPPV 
were treated with the maneuver described by Epley.
8 After 
this maneuver, we suggested self-treatment using the Brand-
Daroff exercise to these patients. The reverse Epley maneu-
ver and barbecue rotation were used for patients with AC 
and HC BPPV, respectively. After the maneuver, we sug-
gested to patients that they lie on the healthy side during the 
following night. For patients with lateral canal cupulolithiasis, 
we recommended a mastoid vibrator or Brand-Daroff exercise 
to detach debris before applying the repositioning maneuver. 
The maneuver was performed several times until reposition-
ing was successful, defined as the absence of nystagmus and 
positional vertigo. The success was determined 2 or 3 days 
after the treatment (at the next follow-up in the outpatient 
department) based on the result of the positioning test. If the 
positioning test was negative, we collected information on the 
presence of any residual dizziness and its characteristics at 
that time, and followed up the patient every week. All of the 
patients were followed up until complete resolution of any 
dizziness (for a maximum of 3 months) via interviews at the 
outpatient clinic or by telephone. The outcome was classified 
as complete or partial recovery, with the latter referring to 
persistent residual dizziness without vertigo after repositioning. 
We compared the characteristics of the patients between 
those with complete recovery and those with partial recovery 
using the independent-samples t-test for continuous variables 
and chi-square test for categorical variables. Logistic regres-
sion analysis was used to identify significant variables ad-
justed for multiple risk factors. We assessed the duration for 
complete resolution of residual dizziness using the Kaplan-
Meier survival curve. All analyses were performed using 
SPSS 11.0 for Windows (SAS Institute, Cary, NC, USA). 
 
Results 
 
Forty-nine patients were enrolled in this prospective study, 
comprising 11 men and 38 women aged 60.4±13.0 years 
(mean±SD; range=34-88 years). The PC, HC, and AC 
Table 1. Demographics, clinical features, and concurrent diseases in the patients
 
Complete recovery  
(no residual dizziness) 
(n=19) 
Partial recovery   
(residual dizziness without vertigo) 
(n=30) 
p 
Age (years) 
Females (%) 
Right side affected (%) 
Involved canal (%) 
 
 
 
Direction of nystagmus (%) 
 
Duration of vertigo (days) 
Total number of vertigo attacks (%) 
 
 
Cause (%) 
 
 
History of BPPV (%) 
Number of repositioning maneuvers (%) 
 
 
Concurrent disease (%) 
 
 
 
Posterior  
Lateral  
Anterior  
Multiple 
Canalolithiasis 
Cupulolithiasis 
 
1–5 
6–10 
>10 
Idiopathic 
Trauma 
VN 
 
1 
2 
3 
 
61.26±9.56 
15 (79) 
10 (53) 
07 (37) 
12 (63) 
0 
0 
15 (79) 
04 (21) 
01.74±2.67 
13 (68) 
03 (16) 
03 (16) 
18 (95) 
01 (5)0 
0 
05 (26) 
17 (89) 
02 (11) 
0 
10 (53) 
59.90±14.94 
23 (77) 
15 (50) 
12 (40) 
16 (53) 
01 (3)0 
01 (3)0 
24 (80) 
06 (20) 
04.73±6.060 
15 (50) 
05 (17) 
10 (33) 
25 (83) 
03 (10) 
02 (7)0 
06 (20) 
23 (77) 
04 (13) 
03 (10) 
11 (37) 
0.73 
0.85 
0.86 
0.68 
 
 
 
0.98 
 
0.04 
0.36 
 
 
0.42 
 
 
0.61 
0.33 
 
 
0.27 
BPPV: benign paroxysmal positional vertigo, VN: vestibular neuronitis    
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were involved in 19, 28, and 1 patient, respectively, with both 
the PC and HC involved in the remaining patient (Table 1). 
Thirty (61%) of the patients complained of residual dizziness 
after successful repositioning, which was characterized by 
continuous or intermittent lightheadedness: 18 patients had 
continuous lightheadedness, 8 had intermittent unsteadiness, 
and 4 had both types of dizziness. The dizziness lasted for 
16.4±17.6 days (range=2-80 days, median=10 days). Fig. 1 
shows the cumulative fractions of residual nonspecific dizzi-
ness during the 3 months follow-up. The residual dizziness 
subsided within 20 days in most patients, and none had dizzi-
ness 3 months later. In univariate and multivariate logistic 
regression analysis, a longer duration of BPPV was signifi-
cantly associated with residual dizziness after successful re-
positioning (p=0.04). Only the duration of BPPV was a sig-
nificant predicting factor (OR=1.27, 95% CI=1.01-1.59). 
The other demographic and clinical parameters were not sig-
nificantly related to the outcome. 
 
Discussion 
 
Two-thirds of the patients included in this study compl-
ained of residual dizziness after successful repositioning. Al-
though the description (usual description of the dizziness) 
alone does not distinguish different types of dizziness, cer-
tain terms are commonly used to describe each type of dizzi-
ness. In this study, the residual dizziness could be classified 
as non-vestibular dizziness, based on the characteristics of 
the residual dizziness and the absence of nausea and vomit-
ing. However, a sensation of spinning does not always indi-
cate a vestibular disorder, and nonvertiginous dizziness does 
not always mean nonvestibular disorder. Therefore, it is dif-
ficult to determine the origin of residual dizziness from only 
its characteristics. 
There are four possible explanations for persistent residual 
dizziness after successful treatment. First, remaining otoco-
nial debris due to incomplete repositioning could produce mild 
positional vertigo, where the remaining debris is insufficient 
to deflect the cupula to a degree sufficient to provoke overt 
nystagmus.
10 Second, BPPV is not only a disorder of the se-
micircular canals but also a disorder of the otoliths that sense 
orientation in space, and otolith dysfunction might account 
for transient mild dizziness.
11,12 Third, another vestibular le-
sion-which is difficult to identify from the history alone-
might coexist with BPPV. A previous study found that the 
prevalence of less-specific persistent dizziness was signifi-
cantly higher in patients with BPPV and additional periph-
eral or central vestibular dysfunction.
13 Fourth, delayed re-
covery might be due to the longer time needed for central 
adaptation after particle repositioning. 
We found that a longer duration of BPPV was associated 
with the presence of residual dizziness after the particle re-
positioning maneuver. A previous study also showed that the 
severity of postural instability estimated after repositioning 
maneuver depended on the disease duration of BPPV.
14 
These findings indicate that early recognition and treatment 
will reduce the incidence of residual dizziness in patients 
with BPPV. 
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